ClinicalTrialsFinder
RecruitingPhase 1NCT07559136

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of HRS9531 Injection in Chinese Adolescents With Obesity

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.

Enrollment

48 participants

Start Date

Jun 12, 2026

Study Type

INTERVENTIONAL

Conditions

Overweight and Obesity

Summary

The aim of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS9531 injection compared with placebo in adolescents with obesity

Eligibility

Min Age: 12 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called HRS9531 injection；Placebo, a drug called HRS9531 injection；Placebo, and others for people with overweight and obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHRS9531 injection；Placebo

Drug: HRS9531 injection; low dose Drug: Placebo

DRUGHRS9531 injection；Placebo

Drug: HRS9531 injection; medium dose Drug: Placebo

DRUGHRS9531 injection；Placebo

Drug: HRS9531 injection; high dose Drug: Placebo

Locations(1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07559136

Related Trials

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

NCT063903455 locations

Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

NCT062829521 location

An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

NCT061479731 location

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

NCT057705701 location

Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources

NCT056814681 location